Bromantane: The Russian Actoprotector
Last updated: October 3, 2026
Bromantane is a Russian-developed compound described in Russian-language literature as an actoprotector; Russian researchers describe it as both anxiolytic and stimulating. In rats it regulates tyrosine hydroxylase (the rate-limiting enzyme in dopamine synthesis) differently across brain regions. It was reported as a new doping agent in 1997 (Burnat et al., Lancet).
🧪 Buy Bromantane at Swiss Chems →Track your vials and inventory on paper
Printable vial and inventory sheets for your own research records. Every value is entered by you. Free to build and preview; $5/month to unlock printing.
What Is Bromantane?
Bromantane (also Bromantan, brand name Ladasten) is an adamantane-based compound developed in Russia. It is described in Russian-language literature as an "actoprotector." It was later identified as a doping agent in elite sport and is prohibited in competition.
In rats, a single oral dose of bromantane (ladasten, 50 mg/kg) differentially regulated tyrosine hydroxylase (TH) mRNA and protein (TH is the rate-limiting enzyme in dopamine synthesis), as well as dopamine and L-DOPA content across five brain regions. It was not a uniform increase, and human data on this mechanism are lacking. (Mikhaylova et al., Neuropharmacology 2007, PMID: 17854844)
Russian researchers describe bromantane (ladasten) as combining psychostimulant and anxiolytic effects, in a pilot clinical trial in patients with psychogenic asthenic disorder (Siuniakov et al., Eksp Klin Farmakol 2006, PMID: 16995430; article in Russian, abstract only). That is a single Russian pilot trial, not independent replication, and the mechanism behind the profile is not established.
Bromantane is described in Russian-language literature as an actoprotector, a drug-class label used in Russian pharmacology; the label is not attributed to any source cited on this page. None of the sources cited on this page measure physical performance, heat tolerance or stress tolerance.
What the Research Shows
What the published sources cited on this page do and do not show.
Research context: Most Bromantane research comes from Russian institutions. The bromantane sources cited on this page are one rat study, one Russian pilot clinical trial (abstract only) and a doping report; Western replication is limited.
Bromantane vs. Modafinil
The cited studies examined different mechanisms (bromantane: TH in rats; modafinil: DAT in humans). This is a comparison of the evidence, not a recommendation.
- Regulates dopamine-synthesis enzyme TH (rat data)
- Described as anxiolytic + psychostimulant (one Russian pilot trial)
- Described in Russian-language literature as an actoprotector (no performance data cited here)
- WADA banned, not for competitive athletes
- No Western randomized trial is cited on this page
- Wake-promoting drug used to treat narcolepsy
- Blocked dopamine transporters and increased extracellular dopamine in a PET study of 10 healthy men (Volkow et al., JAMA 2009, PMID: 19293415)
- Those authors flag potential for abuse in vulnerable populations
Stack note: Some users report combining Bromantane and Modafinil. This is anecdotal: no study cited here tested the combination.
Dosing Protocols
No sourced human dose or cycling schedule exists in the research cited on this page, so we do not list dosing numbers. Nothing here is a medical prescription.
- No sourced human dose range (not listed here)
- No sourced human dose-response data (not listed here)
Onset: users report that effects build gradually over days (anecdotal), though the 2006 Russian pilot trial reported stimulant effects after a single dose. Legal status: Not FDA approved. Banned by WADA for competitive sport. Sold online as a research chemical. WADA Banned Research Chem
Study Citations
Primary research behind the data on this page. Click PMID links to read full papers on PubMed.
Self-Assessment
Who Researches Bromantane?
This Research Is Commonly Explored By People Who...
- Are interested in the Russian "actoprotector" drug classification
- Want to understand bromantane's reported effects on dopamine synthesis
- Are researching compounds described in Russian literature as both anxiolytic and stimulating
- Are curious about Russian pharmaceutical research
- Want to compare bromantane's studied mechanism with modafinil's
This Research May Not Be Relevant If...
- You're looking for an FDA-approved medication: bromantane is not approved in the US or EU
- You want extensive long-term safety data: the bromantane sources cited here are a single rat study, a Russian pilot trial and a doping report
- You're a competitive athlete: bromantane is on WADA's prohibited list
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 20+ compounds, all in one place.
Get the Guide: $19 (normally $29) →
The Protocol & Stack Handbook ($19)
Key Takeaways
An honest assessment of where Bromantane research stands.
- Regulates tyrosine hydroxylase expression in rat brain, differently by region (single-dose rat study)
- Described by Russian researchers as both anxiolytic and psychostimulant (one pilot clinical trial, Siuniakov et al. 2006)
- Identified as a doping agent in elite sport (Burnat et al., Lancet 1997)
- Prohibited in competitive sport (WADA prohibited list)
- No Western randomized trial. The only human bromantane study cited here is a Russian pilot trial
- Long-term safety in humans not established
- Any human dose for non-clinical use
- Interaction profile with other nootropics or pharmaceuticals
- Whether its region-dependent effects on tyrosine hydroxylase persist with repeated dosing
- Purity and quality consistency from research chemical suppliers
Research Source
Research compounds from Swiss Chems, a research-chemical supplier.
Affiliate links support HighPeptides at no extra cost. Swiss Chems publishes third-party HPLC COAs for selected products (vendor-published, a claim to verify).
Recommended Products
Precursor nutrients and support supplements related to the dopamine synthesis pathway.
Affiliate links support HighPeptides at no extra cost.
Related Resources
Related Resources
This page is for educational and informational purposes only. It is not medical advice. Bromantane (Bromantan/Ladasten) is not FDA approved for human use in the United States. It is classified as a banned substance by the World Anti-Doping Agency (WADA) and is prohibited in competitive sport. Research data primarily comes from Russian institutions; independent Western replication is limited. Always consult a qualified healthcare provider before starting any new substance. HighPeptides does not sell Bromantane or endorse its use outside of legitimate research and legal contexts.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.